Shire exits Fabry's market, citing costs as FDA weighs more research
March 15 2012
Shire has pulled its drug, Replagal, from FDA review. The company was set to go before the agency next month, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.